ABTB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.686600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.977600E-01
Normal-vs-Stage2
3.962400E-01
Normal-vs-Stage3
7.161600E-01
Normal-vs-Stage4
5.563000E-01
Stage1-vs-Stage2
1.245990E-01
Stage1-vs-Stage3
4.562000E-01
Stage1-vs-Stage4
2.925000E-01
Stage2-vs-Stage3
7.262800E-01
Stage2-vs-Stage4
9.654600E-01
Stage3-vs-Stage4
8.371400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.901000E-01
Normal-vs-AfricanAmerican
3.536800E-01
Normal-vs-Asian
7.722200E-01
Caucasian-vs-AfricanAmerican
7.477000E-01
Caucasian-vs-Asian
1.354840E-01
AfricanAmerican-vs-Asian
2.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.440200E-01
Normal-vs-Female
5.282200E-01
Male-vs-Female
2.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.863600E-01
Normal-vs-Age(41-60Yrs)
2.811400E-01
Normal-vs-Age(61-80Yrs)
6.051000E-01
Normal-vs-Age(81-100Yrs)
7.751600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.129000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.171200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.684000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.379100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.641200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.337200E-01
Normal-vs-Daily Drinker
5.861200E-01
Normal-vs-Weekly Drinker
8.044600E-01
Normal-vs-Occasional Drinker
3.444400E-01
Normal-vs-Social Drinker
7.290000E-01
Non Drinker-vs-Daily Drinker
8.112200E-01
Non Drinker-vs-Weekly Drinker
2.129600E-01
Non Drinker-vs-Occasional Drinker
3.207400E-01
Non Drinker-vs-Social Drinker
4.514600E-01
Daily Drinker-vs-Weekly Drinker
3.426400E-01
Daily Drinker-vs-Occasional Drinker
2.693800E-01
Daily Drinker-vs-Social Drinker
6.574800E-01
Weekly Drinker-vs-Occasional Drinker
6.181600E-02
Weekly Drinker-vs-Social Drinker
7.053400E-01
Occasional Drinker-vs-Social Drinker
1.694230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.388600E-01
Normal-vs-Grade 2
1.538960E-01
Normal-vs-Grade 3
1.032790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.204150E-03
Grade 1-vs-Grade 3
3.582300E-03
Grade 1-vs-Grade 4
3.388600E-01
Grade 2-vs-Grade 3
9.119600E-01
Grade 2-vs-Grade 4
1.538960E-01
Grade 3-vs-Grade 4
1.032790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.924600E-01
Normal-vs-NonDiabetic
4.336800E-01
Diabetic-vs-NonDiabetic
1.466770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.119400E-01
Normal-vs-NoPancreatitis
4.963000E-01
Pancreatitis-vs-NoPancreatitis
6.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.224600E-01
Normal-vs-N1
3.872400E-01
N0-vs-N1
1.178770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.910600E-01
Normal-vs-TP53-NonMutant
6.652200E-01
TP53-Mutant-vs-TP53-NonMutant
1.78357999999212E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
